Financial reports
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
17 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
9 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Unregistered Sales of Equity Securities
22 Mar 24
8-K
Unregistered Sales of Equity Securities
23 Feb 24
8-K
Other Events
29 Jan 24
8-K
Regulation FD Disclosure
29 Jan 24
8-K
Unregistered Sales of Equity Securities
25 Jan 24
8-K
Other Events
22 Jan 24
8-K
Unregistered Sales of Equity Securities
20 Dec 23
8-K
Other Events
28 Nov 23
8-K
Unregistered Sales of Equity Securities
21 Nov 23
8-K
Other Events
17 Nov 23
Registration and prospectus
424B3
Prospectus supplement
19 Mar 24
SC TO-I/A
Issuer tender offer statement (amended)
7 Mar 24
N-14 8C
Registration statement for closed-end investment company
14 Feb 24
SC TO-I
Issuer tender offer statement
1 Feb 24
SC TO-I/A
Issuer tender offer statement (amended)
1 Feb 24
SC TO-I/A
Issuer tender offer statement (amended)
6 Dec 23
424B3
Prospectus supplement
15 Nov 23
SC TO-I
Issuer tender offer statement
2 Nov 23
SC TO-I/A
Issuer tender offer statement (amended)
2 Nov 23
SC TO-I/A
Issuer tender offer statement (amended)
6 Sep 23
Proxies
No filings
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
15 Mar 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
13 Nov 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11 Aug 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
10 May 23
CORRESP
Correspondence with SEC
9 May 23
EFFECT
Notice of effectiveness
24 Apr 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
17 Mar 23
EFFECT
Notice of effectiveness
7 Jul 22
EFFECT
Notice of effectiveness
6 Oct 20
CORRESP
Correspondence with SEC
26 Aug 20